Stock listing
Frankfurt:MF1 CANbridge Pharmaceuticals Inc. Aktie
German listing (Frankfurt) of CANbridge Pharmaceuticals Inc. · home listing HKEX:1228
Follow CANbridge Pharmaceuticals Inc. into a list and get an email when it puts out news.
Share price · FWB:MF1
€0.151 EUR -0.005 (-3.2%)
Close on Oct 30, 2026
- Day range
- €0.151 – €0.187 EUROct 30, 2026
- Market cap
- €77.18M EURAt the close on Oct 30, 2026 · price × 511.1M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:1228 · Home | $1.73 HKD | -0.04 (-2.3%) | 33,000 | $1.75 | $1.75 | $1.73 | $1.77 | Close on Nov 2, 2026 |
| Frankfurt:MF1 | €0.151 EUR | -0.005 (-3.2%) | — | €0.187 | €0.187 | €0.151 | €0.156 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:MF1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 6, 2026
Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Latest news
Decks
H1 2023 Earnings Presentation
Earnings · 38 slides · Aug 31, 2023
H1 2023 Earnings Presentation
Earnings · 38 slides · Aug 31, 2023
Investor Presentation (August 2023)
Investor deck · 51 slides · August 2023
Investor Presentation (August 2023)
Investor deck · 51 slides · August 2023
CANbridge Pharmaceuticals Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 3 in the last 12 months · 14 in all · newest Oct 6, 2026 · oldest 2021
- Decks
- 10 decks · latest Aug 31, 2023
Where CANbridge Pharmaceuticals Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:1228 北海康成 · Home listing | HKEX | Hong Kong | HKD |
| LS Exchange:A3DGDS | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3DGDS | Lang & Schwarz | Germany | EUR |
| Frankfurt:MF1 · This page | Frankfurt | Germany | EUR |
| OTC:CNBRF | OTC | United States | USD |
Log in to ask 6ix AI your own questions about CANbridge Pharmaceuticals Inc.